Alx Oncology Holdings Income Statement (2019-2026) | ALXO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Shares Outstanding (Entity) (Quarter)																				138.28M
Revenue & cost
Revenue (Quarter)
Operating items
Research & Development (Quarter)	18.21M	20.89M	17.07M	26.75M	29.38M	25.20M	24.76M	29.48M	45.77M	41.78M	31.72M	34.65M	26.47M	23.53M	23.89M	18.02M	17.44M	17.64M	13.61M	13.14M
Selling, General & Administrative (Quarter)	6.36M	7.58M	7.67M	7.04M	7.30M	7.02M	7.44M	7.29M	7.51M	6.24M	6.04M	6.87M	6.10M	7.08M	7.93M	5.45M	5.09M	5.38M	5.36M	5.13M
Restructuring Costs (Quarter)																2.28M				1.87M
Other Operating Expenses (Quarter)																				-2.11M
Operating Expenses (Quarter)																				18.03M
Operating Income (Quarter)																				-18.03M
EBIT (Quarter)																				-18.03M
Non-operating items
Interest & Investment Income (Quarter)																				1.51M
Other Non Operating Income (Quarter)																				-0.90M
Non Operating Income (Quarter)	0.02M	0.02M	0.23M	0.88M	1.37M	1.81M
Net income details
EBT (Quarter)																				-17.67M
Tax Provisions (Quarter)
Profit After Tax (Quarter)																				-17.97M
Income from Continuing Operations (Quarter)																				-17.67M
Consolidated Net Income (Quarter)																				-17.67M
Income towards Parent Company (Quarter)																				-17.67M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)																				-17.67M
Additional items
EPS (Basic) (Quarter)																				-0.13
EPS (Diluted) (Quarter)																				-0.13
Shares Outstanding (Quarter)																				135.64M
Shares Outstanding (Diluted) (Quarter)																				135.64M
EBITDA (Quarter)																				-18.03M
Interest Expenses (Quarter)																				1.14M
Tax Rate (Quarter)